Correlation Between ChitogenX and Regen BioPharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ChitogenX and Regen BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ChitogenX and Regen BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ChitogenX and Regen BioPharma, you can compare the effects of market volatilities on ChitogenX and Regen BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ChitogenX with a short position of Regen BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of ChitogenX and Regen BioPharma.

Diversification Opportunities for ChitogenX and Regen BioPharma

0.03
  Correlation Coefficient

Significant diversification

The 3 months correlation between ChitogenX and Regen is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding ChitogenX and Regen BioPharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regen BioPharma and ChitogenX is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ChitogenX are associated (or correlated) with Regen BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regen BioPharma has no effect on the direction of ChitogenX i.e., ChitogenX and Regen BioPharma go up and down completely randomly.

Pair Corralation between ChitogenX and Regen BioPharma

Assuming the 90 days horizon ChitogenX is expected to generate 0.03 times more return on investment than Regen BioPharma. However, ChitogenX is 36.38 times less risky than Regen BioPharma. It trades about -0.12 of its potential returns per unit of risk. Regen BioPharma is currently generating about -0.08 per unit of risk. If you would invest  0.52  in ChitogenX on September 1, 2024 and sell it today you would lose (0.01) from holding ChitogenX or give up 1.92% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

ChitogenX  vs.  Regen BioPharma

 Performance 
       Timeline  
ChitogenX 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ChitogenX has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Regen BioPharma 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Regen BioPharma are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent basic indicators, Regen BioPharma reported solid returns over the last few months and may actually be approaching a breakup point.

ChitogenX and Regen BioPharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ChitogenX and Regen BioPharma

The main advantage of trading using opposite ChitogenX and Regen BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ChitogenX position performs unexpectedly, Regen BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regen BioPharma will offset losses from the drop in Regen BioPharma's long position.
The idea behind ChitogenX and Regen BioPharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Transaction History
View history of all your transactions and understand their impact on performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio